Browse by Condition in Phoenix
And 73 more conditions with trials in Phoenix
Recruiting Clinical Trials in Phoenix
NCT03851445 · Phase 2/3 · SWOG Cancer Research Network
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
NCT05879926 · Phase 3 · NRG Oncology
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
NCT04267848 · Phase 3 · National Cancer Institute (NCI)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
NCT05174169 · Phase 2/3 · NRG Oncology
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
NCT05929768 · Phase 3 · SWOG Cancer Research Network
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
NCT04871542 · SWOG Cancer Research Network
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
NCT05812807 · Phase 3 · Alliance for Clinical Trials in Oncology
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
NCT04852887 · Phase 3 · NRG Oncology
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
NCT05677490 · Phase 3 · Alliance for Clinical Trials in Oncology
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
NCT02523014 · Phase 2 · Alliance for Clinical Trials in Oncology
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
NCT05334069 · Alliance for Clinical Trials in Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT03937635 · Phase 3 · ECOG-ACRIN Cancer Research Group
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Top Study Sponsors in Phoenix
| Sponsor | Recruiting studies |
|---|---|
| AstraZeneca | 37 |
| National Cancer Institute (NCI) | 30 |
| Eli Lilly and Company | 24 |
| Children's Oncology Group | 20 |
| Mayo Clinic | 20 |
| Pfizer | 19 |
| Arizona State University | 16 |
| Alliance for Clinical Trials in Oncology | 15 |
Trials in Phoenix by Phase
| Phase | Studies |
|---|---|
| Early Phase 1 | 7 |
| Phase 1 | 52 |
| Phase 1/2 | 51 |
| Phase 2 | 155 |
| Phase 2/3 | 27 |
| Phase 3 | 284 |
| Phase 4 | 23 |
| Not phased | 260 |
62 of these studies accept healthy volunteers.
Clinical Trials in Phoenix: Common Questions
How many clinical trials are recruiting in Phoenix, AZ?
859 clinical trials list a recruiting site in Phoenix, AZ, across 103 conditions on HelloStudys. Counts update daily from ClinicalTrials.gov.
What conditions are being studied in Phoenix?
The most active research areas in Phoenix right now are rheumatoid arthritis, ankylosing spondylitis, heart attack. Browse by condition above to see each study.
Who sponsors clinical trials in Phoenix?
The sponsors with the most recruiting studies in Phoenix include AstraZeneca, National Cancer Institute (NCI), Eli Lilly and Company.
Are there clinical trials for healthy volunteers in Phoenix?
Yes. 62 of the recruiting studies in Phoenix accept healthy volunteers.
Does it cost anything to join a clinical trial?
Study-related visits, tests and treatment are typically provided at no cost to participants, and some studies reimburse travel or time. Each study sets its own terms, so confirm with the study team before enrolling.
About Clinical Trials in Phoenix, AZ
Phoenix, AZ is home to 859 actively recruiting clinical trials across 103 medical conditions as of 2026. The most active research areas include rheumatoid arthritis, ankylosing spondylitis, heart attack. Clinical trials offer free access to new treatments and expert medical care. Participation is always voluntary, and you can withdraw at any time.